Abstract
At present, Levovist is the only commercially available ultrasonic contrast agent in Japan. It is based on galactose and palmitic acid forming microbubbles which produces harmonic signals under ultrasonic pressure. In addition, Definity, Optison, and NC 100/100 are also now being investigated in Japan (Table 20–1). It has been reported that these contrast agents do not need intermittent transmission because they are propane fluoride agents, and clear images can be visualized in near-real time in combination with pulse inversion harmonics. Contrast technique using ordinary B-mode equipment has also been studied. Therefore, a contrast effect may be obtained to a certain extent by using existing old B-mode equipment. NC 100/100 has a high deposit affinity for Kupffer cells or the endothelial cells of sinusoids and a promising application of this agent is the postvascu-lar phase sweep scan 5 or 10 min after administration.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schrope B, Newhouse VL, Uhlendorf V: Simulated capillary blood flow measurement using a nonlinear ultrasonic contrast agent. Ultrason Imaging 1992; 14:134–158
Burns PN: Harmonic imaging with ultrasound contrast agents. Clin Radiol 1996; 51(Suppl l):50–55
Shanker PM, Keiahn PD, Newhouse VL: Advantage of subharmonic over second harmonic backscatter for contrast-to-tissue echo enhancement. Ultrasound Med Biol 1998; 24:395–399
Shi WT, Forsberg F, Hall AL, et al: Subharmonic imaging with microbubble contrast agents: initial results. Ultrason Imaging 1999; 21:79–94
Forsberg F, Shi WT, Goldberg BB: Subharmonic imaging of contrast agents. Ultrasonics 2000; 38:93–98
Burns PN, Wilson SR, Simpson DH: Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000; 35:58–71
Apfel RE, Holland CK: Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound. Ultrasound Med Biol 1991; 17:179–185
Klibanov AL, Ferrara KW, Hughes MS, et al: Direct video-microscopic observation of the dynamic effects of medical ultrasound on ultrasound contrast microspheres. Invest Radiol 1998; 33:863–870
Albrecht T, Hoffmann CW, Schettler S, et al: B-mode enhancement at phase-inversion US with air-based microbubble contrast agent: initial experience in humans. Radiology 2000; 216:273–278
Blomley MJ, Albrecht T, Cosgrove DO, et al: Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. Radiology 1999; 210:409–416
Uchimoto R, Niwa K, Eguchi H, et al: In vivo kinetics of microbubbles of SH U 508A (Levovist): comparison with indocyanine green in rabbits. Ultrasound Med Biol 1999; 25:1365–1370
Tanaka S, Kitamura T, Yoshioka F, et al: Effectiveness of galactose-based intravenous contrast medium on color Doppler sonography of deeply located hepatocellular carcinoma. Ultrasound Med Biol 1995; 12:157–160
Tanaka S, Kitamura T, Fujita M, et al: Value of contrast-enhanced color Doppler sonography in diagnosing hepatocellular carcinoma with special attention to the “color-filled pattern.” J Clin Ultrasound 1998; 26:207–212
Kim AY, Choi BI, Kim TK, et al: Hepatocellular carcinoma: power Doppler US with a contrast agent: preliminary results. Radiology 1998; 209:135–140
Hosten N, Puls R, Lemke AJ, et al: Contrast enhanced power Doppler sonography: improved detection of characteristic flow patterns in focal liver lesions. J Clin Ultrasound 1999; 27:107–115
Bartolozzi C, Lencioni R, Ricci P, et al: Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast enhanced color Doppler US. Radiology 1998; 209:135–140
Solbiati L, Goldberg SN, Lerace T, et al: Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent: early experience. Radiology 1999; 211:643–649
Uggowitxer M, Kugler C, Groll R, et al: Sonographic evaluation of focal nodular hyperplasias (FNH) of the liver with a trans-pulmonary galactose-based contrast agent (Levovist). Br J Radiol 1998; 71:1026–1032
Blomley MJ, Albrecht T, Cosgrove DO, et al: Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: early experience in seven patients with metastases. Radiology 1998; 209:862–866
Forsberg F, Liu JB, Burns PN, et al: Artifacts in ultrasonic contrast agent studies. J Ultrasound Med 1994; 13:357–365
Petrich J, Zomack M, Schilief R: An investigation of the relationship between ultrasound echo enhancement and Doppler frequency shift using a pulsatile arterial flow phantom. Invest Radiol 1997; 32:225–235
Darge K, Troeger J, Duetting T, et al: Reflux in young patients: comparison of voiding US of the bladder and retrovesical space with echo enhancement versus voiding cystourethrography for diagnosis. Radiology 1999; 210:201–207
Hauff P, Fritzsch T, Reinhardt M, et al: Delineation of experimental liver tumors in rabbits by a new ultrasound contrast agent and stimulated acoustic emission. Invest Radiol 1997; 32:94–99
Goldberg BB, Merton DA, Liu JB, et al: Evaluation of bleeding sites with a tissue-specific sonographic contrast agent: preliminary experiences in an animal model. J Ultrasound Med 1998; 17:609–616
Forsberg F, Goldberg BB, Liu JB, et al: Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma. Radiology 1999; 210:125–132
Wu Y, Unger EC, McCreery TP, et al: Binding and lysing of blood clots using MRX-408. Invest Radiol 1998; 33:880–885
Takeuchi M, Ogunyankin K, Pandian NG, et al: Enhanced visualization of intravascular and left atrial appendage thrombus with the use of a thrombus-targeting ultrasonographic contrast agent (MRX-408A1): in vivo experimental echocardiographic studies. J Am Soc Echocardiogr 1999; 12:1015–1021
Unger E, Metzger P 3rd, Krupinski E, et al: The use of a thrombus-specific ultrasound contrast agent to detect thrombus in arteriovenous fistulae. Invest Radiol 2000; 35:86–89
Kim TK, Choi BI, Han JK, et al: Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 2000; 216:411–417
Ding H, Kudo M, Onda H, et al: Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma. AJR 2001; 176:661–666
Ding H, Kudo M, Onda H, et al: Hepatocellular carcinoma: detection of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode. Radiology 2001; 220:349–356
Ding H, Kudo M, Onda H, et al: Sonographic diagnosis of pancreatic islet cell tumor: value of intermittent harmonic imaging. J Clin Ultrasound 2001; 29:411–416
Kudo M: Morphological diagnosis of hepatocellular carcinoma: special emphasis on intranodular hemodynamic imaging. Hepato-Gastroenterology 1998; 45:1226–1231
Kudo M: Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin Liver Dis 1999; 19:297–309
Kudo M: Imaging blood flow characteristics of hepatocellular carcinoma. Oncology 2002; 62(Suppl l):48–56
Ding H, Kudo M, Maekawa K, et al: Detection of tumor parenchymal blood flow in hepatic tumors: value of second harmonic imaging with a galactose-based contrast agent. Hepatol Res 2001; 21:242–251
Ding H, Kudo M, Onda H, et al: Evaluation of posttreat-ment response for hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 2001; 221:721–730
Kudo M: Contrast harmonic ultrasound is a breakthrough technology in the diagnosis and treatment of hepatocellular carcinoma. J Med Ultrasonics 2001; 28:79–81
Wen YL, Kudo M, Kawasaki T, et al: Hepatocellular carcinoma treated with radiofrequency ablation: Evaluation of therapeutic response by contrast-enhanced Coded Harmonic Angio. Chinese J Ultrasound in Med 2002; 18:452–455
Wen YL, Kudo M, Maekawa K, et al: Evaluation of image quality of personal ultrasound imager: comparison with conventional machine. J Med Ultrasonics 2002; 29:41–46
Zheng RQ, Kudo M, Inui K, et al: Transient portal vein thrombosis caused by radiofrequency ablation for hepatocellular carcinoma. J Gastroenterol 2003; 38:101–103
Wen YL, Kudo M, Minami Y, et al: Value of newly developed contrast harmonic technique in detection tumor vascularity in hepatocellular carcinoma—preliminary results. J Med Ultrasonics 2003 (in press)
Wen YL, Kudo M, Minami Y, et al: Assessment of image quality of contrast-enhanced power Doppler imaging in hepatocellular carcinoma with a personal ultrasound imager: comparison with conventional machine. J Med Ultrasonics 2003 (in press)
Wen YL, Kudo M, Minami Y, et al: Detection of tumor vascularity in hepatocellular carcinoma with contrast enhanced Dynamic Flow imaging: comparison with contrast enhanced power Doppler imaging. J Med Ultrasonics 2003 (in press)
Wen YL, Kudo M, Minami Y, et al: Contrast-enhanced Agent Detection Imaging: preliminary study in hepatocellular carcinoma. J Med Ultrasonics 2003 (in press)
Wen YL, Kudo M, Maekawa K, et al: Contrast advanced dynamic flow imaging and contrast pulse subtraction imaging: preliminary results in hepatic tumors. J Med Ultrasonics 2003 (in press)
Minami Y, Kudo M, Kawasaki, et al: Trascatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography. AJR 2003; 180:703–708
Wen YL, Kudo M, Minami Y, et al: Radio-frequency ablation in hepatocellular carcinoma: evaluation of therapeutic response by contrast-enhanced coded phase inversion harmonic imaging. AJR 2003 (in press)
Wen YL, Kudo M, Maekawa K, et al: Contrast Advenced Dynamic Flow imaging and contrast Pulse Subtraction imaging: pre-liminary results in hepatic tumors. J Med Ultrasonics 2002; 27:195–204
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Japan
About this chapter
Cite this chapter
Kudo, M. (2003). Update and Direction of Ultrasonic Contrast Agents. In: Contrast Harmonic Imaging in the Diagnosis and Treatment of Hepatic Tumors. Springer, Tokyo. https://doi.org/10.1007/978-4-431-65904-4_20
Download citation
DOI: https://doi.org/10.1007/978-4-431-65904-4_20
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-65906-8
Online ISBN: 978-4-431-65904-4
eBook Packages: Springer Book Archive